Legis Daily

To require the use of prescription drug monitoring programs and to facilitate information sharing among States.

USA115th CongressHR-1854| House 
| Updated: 4/24/2017
Evan H. Jenkins

Evan H. Jenkins

Republican Representative

West Virginia

Cosponsors (5)
Daniel M. Donovan (Republican)Tim Ryan (Democratic)Stephen Knight (Republican)Gerald E. Connolly (Democratic)Barbara Comstock (Republican)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Prescription Drug Monitoring Act of 2017 This bill requires a state that receives grant funds under the prescription drug monitoring program (PDMP) or the controlled substance monitoring program to comply with specified requirements, including a requirement to share its PDMP data with other states. The Department of Justice (DOJ) or Department of Health and Human Services may withhold grant funds from a state that fails to comply. To facilitate data sharing among states, the bill directs DOJ to award a grant under the Comprehensive Opioid Abuse Grant Program to establish and maintain a data-sharing hub.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 30, 2017

Latest Companion Bill Action

S 115-778
Introduced in Senate
Apr 3, 2017
Introduced in House
Apr 3, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 24, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • March 30, 2017

    Latest Companion Bill Action

    S 115-778
    Introduced in Senate


  • April 3, 2017
    Introduced in House


  • April 3, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 7, 2017
    Referred to the Subcommittee on Health.


  • April 24, 2017
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Health

Related Bills

  • S 115-778: A bill to require the use of prescription drug monitoring programs and to facilitate information sharing among States.
Drug trafficking and controlled substancesHealth information and medical recordsHealth personnelIntergovernmental relationsPrescription drugsState and local government operations

To require the use of prescription drug monitoring programs and to facilitate information sharing among States.

USA115th CongressHR-1854| House 
| Updated: 4/24/2017
Prescription Drug Monitoring Act of 2017 This bill requires a state that receives grant funds under the prescription drug monitoring program (PDMP) or the controlled substance monitoring program to comply with specified requirements, including a requirement to share its PDMP data with other states. The Department of Justice (DOJ) or Department of Health and Human Services may withhold grant funds from a state that fails to comply. To facilitate data sharing among states, the bill directs DOJ to award a grant under the Comprehensive Opioid Abuse Grant Program to establish and maintain a data-sharing hub.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 30, 2017

Latest Companion Bill Action

S 115-778
Introduced in Senate
Apr 3, 2017
Introduced in House
Apr 3, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 24, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • March 30, 2017

    Latest Companion Bill Action

    S 115-778
    Introduced in Senate


  • April 3, 2017
    Introduced in House


  • April 3, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 7, 2017
    Referred to the Subcommittee on Health.


  • April 24, 2017
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Evan H. Jenkins

Evan H. Jenkins

Republican Representative

West Virginia

Cosponsors (5)
Daniel M. Donovan (Republican)Tim Ryan (Democratic)Stephen Knight (Republican)Gerald E. Connolly (Democratic)Barbara Comstock (Republican)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Health

Related Bills

  • S 115-778: A bill to require the use of prescription drug monitoring programs and to facilitate information sharing among States.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug trafficking and controlled substancesHealth information and medical recordsHealth personnelIntergovernmental relationsPrescription drugsState and local government operations